49 related articles for article (PubMed ID: 2169831)
1. Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression.
Ma Y; Liu Y; Meng H
Medicine (Baltimore); 2023 Nov; 102(45):e35634. PubMed ID: 37960806
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
Ustach CV; Kim HR
Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
[TBL] [Abstract][Full Text] [Related]
3. Mycoplasma fermentans binds to and invades HeLa cells: involvement of plasminogen and urokinase.
Yavlovich A; Katzenell A; Tarshis M; Higazi AA; Rottem S
Infect Immun; 2004 Sep; 72(9):5004-11. PubMed ID: 15321992
[TBL] [Abstract][Full Text] [Related]
4. Complexity of matrix phenotypes.
Iozzo RV; Theocharis AD; Neill T; Karamanos NK
Matrix Biol Plus; 2020 May; 6-7():100038. PubMed ID: 33543032
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
6. YY1 Facilitates Enhancer-Promoter Contacts to Promote Gene Expression.
Cancer Discov; 2018 Feb; 8(2):135. PubMed ID: 29247020
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis tunneled-cuffed catheter-related atrial thrombus complicated with asymptomatic pulmonary emboli.
Zhang Z; Zhang D
J Vasc Access; 2018 Mar; 19(2):197-198. PubMed ID: 29147998
[No Abstract] [Full Text] [Related]
8. Capecitabine Extends Survival for Biliary Tract Cancer.
Cancer Discov; 2017 Jul; 7(7):OF1. PubMed ID: 28572460
[TBL] [Abstract][Full Text] [Related]
9. The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade.
Xu Q; Wang L; Luo J; Shi D
Curr Drug Targets; 2018; 19(1):55-69. PubMed ID: 28270085
[TBL] [Abstract][Full Text] [Related]
10. Exertional Rhabdomyolysis: Epidemiology, Diagnosis, Treatment, and Prevention.
Knapik JJ; O'Connor FG
J Spec Oper Med; 2016; 16(3):65-71. PubMed ID: 27734446
[TBL] [Abstract][Full Text] [Related]
11. Effect of Mast Cell Chymase on Activation, Proliferation and Transdifferentiation of Hepatic Stellate Cells.
Yin M; Wu L
Hepatogastroenterology; 2015 Jun; 62(140):1007-10. PubMed ID: 26902046
[TBL] [Abstract][Full Text] [Related]
12. Consecutive laser in situ keratomileusis and accelerated corneal crosslinking in highly myopic patients: preliminary results.
Tan J; Lytle GE; Marshall J
Eur J Ophthalmol; 2014 Dec; ():0. PubMed ID: 25588591
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized placebo-controlled trial of low-dose aspirin for prevention of intra-uterine growth retardation.
Wang Z; Li W
Chin Med J (Engl); 1996 Mar; 109(3):238-42. PubMed ID: 8758317
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
[TBL] [Abstract][Full Text] [Related]
15. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
Niedbala MJ; Sartorelli AC
Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.
Niedbala MJ; Sartorelli AC
Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433
[TBL] [Abstract][Full Text] [Related]
17. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
18. The receptor for urokinase-plasminogen activator.
Blasi F; Stoppelli MP; Cubellis MV
J Cell Biochem; 1986; 32(3):179-86. PubMed ID: 3023408
[TBL] [Abstract][Full Text] [Related]
19. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
